Inspired by the successful television series, the UCL School of Pharmacy has organised this clever and well-attended event where UCL scientists presented their small molecule therapeutics idea to a panel of seasoned pharma experts and investors, in front of a public of scientists and company representatives. We couldn’t resist the temptation to pitch our Virology Research Services, and although VRS is not quite a small molecule, it was clearly exciting enough to win the third prize from the public! Thank you!
Recents Posts
Introducing Our Free TCID50 Calculator: Addressing Real Workflow Challenges in Virology
TL;DR: Streamline your viral titer assays with our free TCID50 Calculator for fast, accurate Reed-Muench or Spearman-Kärber results. Why TCID50 Accuracy MattersThe Current TCID50 Calculation LandscapeOur Solution: Purpose-Built for Modern Laboratory WorkflowsFlexible...
Immunity in Action: How the Body Outsmarts Viral Invaders
Every day, our bodies face an invisible war – one waged against viruses, bacteria, and other microbial threats. At the heart of this battle is the immune system: a complex, adaptive network that defends us with precision and memory. Far from being a simple protective...
Membrane Mysteries: How Viruses Navigate Cell Entry
In our previous exploration of viral architecture, we examined how the capsid’s elegant structure protects viral genomes – the apparatus in which a virus stores and protects its genetic material. We discussed how viruses are not capable of replicating this genetic...
When it comes to viruses, we know our stuff!
Subscribe